This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, D C Articles by Hancock, J F Search for Related Content PubMed PubMed Citation Articles by Huang, D C Articles by Hancock, J F

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 April; 13(4): 2420-2431

Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function.

D C Huang, C J Marshall and J F Hancock

Department of Haematology, Royal Free Hospital School of Medicine, London, United Kingdom.

ABSTRACT

Although p21ras is localized to the plasma membrane, proteins it interacts with, such as the GTPase-activating proteins (GAPs) ras GAP and neurofibromin (NF1), are not, suggesting that one function of p21ras GTP may be to target such proteins to the plasma membrane. To investigate the effects of targeting ras GAP to the plasma membrane, ras C-terminal motifs sufficient for plasma membrane localization of p21ras were cloned onto the C terminus of ras GAP. Plasma membrane-targeted ras GAP is growth inhibitory to NIH 3T3 fibroblasts and COS cells. This growth inhibition correlates with GAP catalytic activity, since the plasma membrane-targeted C-terminal catalytic domain or the GAP-related domain of neurofibromin is inhibitory, whereas the similarly targeted N-terminal domain is not. Moreover, the inhibition is abrogated by the inactivating mutation L902I, which abolishes ras GAP catalytic activity. Coexpression of oncogenic mutant ras rescues cell viability, but the majority of rescued colonies are phenotypically untransformed. Furthermore, in focus assays, targeted ras GAP suppresses transformation by oncogenic mutant ras, and in reversion assays, targeted ras GAP can revert cells transformed by oncogenic mutant ras. Neither the targeted or nontargeted N-terminal domain nor the L902I mutant of ras GAP has any transforming activity. These data demonstrate that ras GAP can function as a negative regulator of ras and that plasma membrane localization potentiates this activity. However, if ras GAP is involved in the effector functions of p21ras, it can only be part of the effector complex for cell transformation.

---

Mol Cell Biol. 1993 April; 13(4): 2420-2431

This article has been cited by other articles:

• Okeley, N. M., Gelb, M. H. (2004). A Designed Probe for Acidic Phospholipids Reveals the Unique Enriched Anionic Character of the Cytosolic Face of the Mammalian Plasma Membrane. J. Biol. Chem. 279: 21833-21840 [Abstract] [Full Text]  
• Harding, A., Hsu, V., Kornfeld, K., Hancock, J. F. (2003). Identification of Residues and Domains of Raf Important for Function in Vivo and in Vitro. J. Biol. Chem. 278: 45519-45527 [Abstract] [Full Text]  
• Yan, J., Roy, S., Apolloni, A., Lane, A., Hancock, J. F. (1998). Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase. J. Biol. Chem. 273: 24052-24056 [Abstract] [Full Text]  
• Leblanc, V., Tocque, B., Delumeau, I. (1998). Ras-GAP Controls Rho-Mediated Cytoskeletal Reorganization through Its SH3 Domain. Mol. Cell. Biol. 18: 5567-5578 [Abstract] [Full Text]  
• Roy, S., McPherson, R. A., Apolloni, A., Yan, J., Lane, A., Clyde-Smith, J., Hancock, J. F. (1998). 14-3-3 Facilitates Ras-Dependent Raf-1 Activation In Vitro and In Vivo. Mol. Cell. Biol. 18: 3947-3955 [Abstract] [Full Text]  
• Roy, S., Lane, A., Yan, J., McPherson, R., Hancock, J. F. (1997). Activity of Plasma Membrane-recruited Raf-1 Is Regulated by Ras via the Raf Zinc Finger. J. Biol. Chem. 272: 20139-20145 [Abstract] [Full Text]  
• Zlatkine, P, Mehul, B, Magee, A. (1997). Retargeting of cytosolic proteins to the plasma membrane by the Lck protein tyrosine kinase dual acylation motif. J. Cell Sci. 110: 673-679 [Abstract]  
• Bollag, G., Adler, F., elMasry, N., McCabe, P. C., Conner, E. Jr., Thompson, P., McCormick, F., Shannon, K. (1996). Biochemical Characterization of a Novel KRAS Insertion Mutation from a Human Leukemia. J. Biol. Chem. 271: 32491-32494 [Abstract] [Full Text]  
• Porfiri, E., McCormick, F. (1996). Regulation of Epidermal Growth Factor Receptor Signaling by Phosphorylation of the Ras Exchange Factor hSOS1. J. Biol. Chem. 271: 5871-5877 [Abstract] [Full Text]  
• Bryant, S. S., Mitchell, A. L., Collins, F., Miao, W., Marshall, M., Jove, R. (1996). N-terminal Sequences Contained in the Src Homology 2 and 3 Domains of p120 GTPase-activating Protein Are Required for Full Catalytic Activity Toward Ras. J. Biol. Chem. 271: 5195-5199 [Abstract] [Full Text]  
• Freed, E, Symons, M, Macdonald, S., McCormick, F, Ruggieri, R (1994). Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 265: 1713-1716 [Abstract]  
• Stokoe, D, Macdonald, S., Cadwallader, K, Symons, M, Hancock, J. (1994). Activation of Raf as a result of recruitment to the plasma membrane. Science 264: 1463-1467 [Abstract]  
• Mollat, P, Fournier, A, Yang, C., Alsat, E, Zhang, Y, Evain-Brion, D, Grassi, J, Thang, M. (1994). Species specificity and organ, cellular and subcellular localization of the 100 kDa Ras GTPase activating protein. J. Cell Sci. 107: 427-435 [Abstract]  
• Freed, E., McCormick, F., Ruggieri, R. (1994). Proteins of the 14-3-3 Family Associate with Raf and Contribute to Its Activation. Cold Spring Harb Symp Quant Biol 59: 187-193 [Abstract]  
• Clyde-Smith, J., Silins, G., Gartside, M., Grimmond, S., Etheridge, M., Apolloni, A., Hayward, N., Hancock, J. F. (2000). Characterization of RasGRP2, a Plasma Membrane-targeted, Dual Specificity Ras/Rap Exchange Factor. J. Biol. Chem. 275: 32260-32267 [Abstract] [Full Text]